- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Medirom stock soars after joining Sam Altman's World ID protocol | 4 | Investing.com | ||
| MEDIROM HEALTHCARE TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| Do | MEDIROM Healthcare Technologies Inc.: Medirom Decides to Double Installation of Authentication Device "Orb" to 200 Stores, in Collaboration with "World" Co-founded by Sam Altman and Alex Blania | 7 | GlobeNewswire (USA) | ||
| Do | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 17 | SEC Filings | ||
| 18.09. | MEDIROM Healthcare Technologies Inc.: Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs' REMONY for Advanced Health Monitoring and Heatstroke Safety | 5 | GlobeNewswire (USA) | ||
| 18.09. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 28.08. | MEDIROM Healthcare Technologies Inc.: Medirom's "REMONY" Certified by MLIT as a Fatigue-Driving Prevention Device | 1 | GlobeNewswire (USA) | ||
| 28.08. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 22.08. | MEDIROM to install World ID authentication devices at Re.Ra.Ku salons | 1 | Investing.com | ||
| 22.08. | MEDIROM Healthcare Technologies Inc.: MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World" | 1.231 | GlobeNewswire (Europe) | TOKYO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM) (the "Company", "we" or "us"), which operates a diversified... ► Artikel lesen | |
| 20.08. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.08. | Medirom Healthcare Surges Over 79% In Pre-Market After Deal To Deploy Sam Altman-Backed World ID | 11 | Benzinga.com | ||
| 01.08. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 21.07. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.06. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 20.06. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 05.06. | MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements | 300 | GlobeNewswire (Europe) | NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM" or the "Company"), today announced that on... ► Artikel lesen | |
| 30.05. | MEDIROM Healthcare Technologies Inc.: Specific Health Guidance Service Utilizing the "Lav" Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals! | 1 | GlobeNewswire (USA) | ||
| 30.05. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.05. | MEDIROM Healthcare Technologies - ADS GAAP EPS of ¥28.52, revenue of ¥8.3B | 1 | Seeking Alpha | ||
| 20.05. | MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET | 2 | GlobeNewswire (USA) |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,108 | -3,57 % | Sernova Biotherapeutics Inc: Sernova Biotherapeutics appoints Brooks chairman | ||
| ATOSSA THERAPEUTICS | 0,688 | -1,01 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
| PING AN HEALTHCARE | 1,956 | +0,31 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,015 | +13,64 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,330 | +0,61 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| VERU | 3,740 | +4,18 % | VERU INC. - 8-K, Current Report | ||
| CYTOSORBENTS | 0,764 | +0,53 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| VOLITIONRX | 0,613 | 0,00 % | VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, August 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Aug. 14, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
| EKSO BIONICS | 5,080 | +8,32 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 4,240 | -4,93 % | Imunon's Phase III-stage IL-12 gene therapy alters tumour microenvironment in ovarian cancer | ||
| BEYOND AIR | 2,470 | +6,01 % | Beyond Air registers 719,561 shares for potential resale by warrant holders | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,429 | -4,25 % | Novacyt veröffentlicht ungeprüfte Halbjahresergebnisse 2025 am 30. September | ||
| AROVELLA THERAPEUTICS | 0,046 | -7,07 % | AROVELLA THERAPEUTICS LIMITED: ALA presents at ASX SMIDcaps Conference |
MEDIROM HEALTHCARE TECHNOLOGIES INC ADR gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,940 Euro und damit +102,76 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDIROM HEALTHCARE TECHNOLOGIES INC ADR finden Sie auf Wallstreet Online.